Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Xing

Showing results (511-520 of 533) with videos related to

Pageof 54
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2026
A multimodal MRI-radiomics deep learning model for survival risk stratification after gamma knife radiosurgery in patients with brain metastases: A multicenter retrospective studyYijun Chen, Qingyu Yuan, Christina K Cramer, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
Oncogene|August 30, 2019
TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironmentSherona R Sirkisoon, Richard L Carpenter, Tadas Rimkus, et al.
Nature Communications|July 4, 2025
Natural variation of AcEGY3 mediates chloroplastic ROS homeostasis to confer kiwifruit thermotoleranceChengcheng Ling, Jun Yang, Jiale Xu, et al.
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Breast Cancer Research and Treatment|December 29, 2010
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthasePuspa R Pandey, Hiroshi Okuda, Misako Watabe, et al.
European Journal of Epidemiology|March 22, 2017
The Born in Guangzhou Cohort Study (BIGCS)Xiu Qiu, Jin-Hua Lu, Jian-Rong He, et al.
Pageof 54

Showing results (511-520 of 533) with videos related to

Sort By:
Pageof 54
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2026
A multimodal MRI-radiomics deep learning model for survival risk stratification after gamma knife radiosurgery in patients with brain metastases: A multicenter retrospective studyYijun Chen, Qingyu Yuan, Christina K Cramer, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
Oncogene|August 30, 2019
TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironmentSherona R Sirkisoon, Richard L Carpenter, Tadas Rimkus, et al.
Nature Communications|July 4, 2025
Natural variation of AcEGY3 mediates chloroplastic ROS homeostasis to confer kiwifruit thermotoleranceChengcheng Ling, Jun Yang, Jiale Xu, et al.
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
Cancer Research|September 9, 2024
Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung CancerMargaret R Smith, Caroline B Dixon, Yuezhu Wang, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Breast Cancer Research and Treatment|December 29, 2010
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthasePuspa R Pandey, Hiroshi Okuda, Misako Watabe, et al.
European Journal of Epidemiology|March 22, 2017
The Born in Guangzhou Cohort Study (BIGCS)Xiu Qiu, Jin-Hua Lu, Jian-Rong He, et al.
Pageof 54